Cargando…

Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus

BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Hanna, Porter, Kyle, Sill, Bruce, Nahata, Milap C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437484/
https://www.ncbi.nlm.nih.gov/pubmed/23127148
http://dx.doi.org/10.18553/jmcp.2012.18.8.607
_version_ 1785092535021993984
author Phan, Hanna
Porter, Kyle
Sill, Bruce
Nahata, Milap C.
author_facet Phan, Hanna
Porter, Kyle
Sill, Bruce
Nahata, Milap C.
author_sort Phan, Hanna
collection PubMed
description BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for adolescents and young adults with T2DM. METHODS: A retrospective, cross-sectional analysis was conducted on office visits of adolescents (12-17 years) and young adults (18-39 years) with T2DM or impaired glucose tolerance (IGT), using the National Ambulatory Medical Care Survey (NAMCS) from 1996-2005. Logistic regression was used to test for prescribing trends over time. RESULTS: There were an estimated 1.6 million (93.7% T2DM; 4.4% T2DM + IGT; 1.9% IGT) and 22.2 million (88.1% T2DM; 11.9% IGT) office visits for adolescents (0.4% of all adolescent visits) and young adults (1.2% of all young adult visits) associated with T2DM based on ICD-9-CM codes, respectively. In young adults, diabetes drug mentions increased significantly from 39% of visits with T2DM to 61% in 2004-2005 (P = 0.04). Oral diabetes medication mentions increased from 20% to 49% (P = 0.001). However, reports of nonpharmacological therapy decreased from 53% in 1996-1997 to 37% in 2004-2005 (P = 0.14). CONCLUSIONS: The prescribing of pharmacological treatment for T2DM increased with emphasis on oral agents, while reports of nonpharmacological therapy for T2DM decreased over the 9-year study period with increased use of oral medications in both adolescents and young adults. Health care providers should consistently consider both treatment approaches when prescribing patient care as recommended by treatment guidelines.
format Online
Article
Text
id pubmed-10437484
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104374842023-08-21 Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus Phan, Hanna Porter, Kyle Sill, Bruce Nahata, Milap C. J Manag Care Pharm Research BACKGROUND: Little is known about U.S. outpatient prescribing trends for type 2 diabetes (T2DM) in adolescents and young adults. OBJECTIVES: To determine (a) trends in the outpatient prescribing of pharmacological and nonpharmacological therapies and (b) factors influencing prescribing trends for adolescents and young adults with T2DM. METHODS: A retrospective, cross-sectional analysis was conducted on office visits of adolescents (12-17 years) and young adults (18-39 years) with T2DM or impaired glucose tolerance (IGT), using the National Ambulatory Medical Care Survey (NAMCS) from 1996-2005. Logistic regression was used to test for prescribing trends over time. RESULTS: There were an estimated 1.6 million (93.7% T2DM; 4.4% T2DM + IGT; 1.9% IGT) and 22.2 million (88.1% T2DM; 11.9% IGT) office visits for adolescents (0.4% of all adolescent visits) and young adults (1.2% of all young adult visits) associated with T2DM based on ICD-9-CM codes, respectively. In young adults, diabetes drug mentions increased significantly from 39% of visits with T2DM to 61% in 2004-2005 (P = 0.04). Oral diabetes medication mentions increased from 20% to 49% (P = 0.001). However, reports of nonpharmacological therapy decreased from 53% in 1996-1997 to 37% in 2004-2005 (P = 0.14). CONCLUSIONS: The prescribing of pharmacological treatment for T2DM increased with emphasis on oral agents, while reports of nonpharmacological therapy for T2DM decreased over the 9-year study period with increased use of oral medications in both adolescents and young adults. Health care providers should consistently consider both treatment approaches when prescribing patient care as recommended by treatment guidelines. Academy of Managed Care Pharmacy 2012-10 /pmc/articles/PMC10437484/ /pubmed/23127148 http://dx.doi.org/10.18553/jmcp.2012.18.8.607 Text en Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
Phan, Hanna
Porter, Kyle
Sill, Bruce
Nahata, Milap C.
Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title_full Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title_fullStr Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title_full_unstemmed Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title_short Prescribing Trends for the Outpatient Treatment of Adolescents and Young Adults with Type 2 Diabetes Mellitus
title_sort prescribing trends for the outpatient treatment of adolescents and young adults with type 2 diabetes mellitus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437484/
https://www.ncbi.nlm.nih.gov/pubmed/23127148
http://dx.doi.org/10.18553/jmcp.2012.18.8.607
work_keys_str_mv AT phanhanna prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus
AT porterkyle prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus
AT sillbruce prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus
AT nahatamilapc prescribingtrendsfortheoutpatienttreatmentofadolescentsandyoungadultswithtype2diabetesmellitus